XML 17 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Note 2 - Income Tax Disclosure
12 Months Ended
Sep. 30, 2025
Notes  
Note 2 - Income Tax Disclosure

Note 2 - Income Taxes. At September 30, 2025, the Company had a depletion carryforward of $860,000 and a net operating loss carryforward of $1,989,000, of which $1,594,000 will expire in the years 2029 through 2040. The approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax assets at September 30, 2025, computed in accordance with the Income Tax Topic (Topic 740) of the Codification, is as follows:

 

Deferred Tax Assets

 

2025

 

2024

 Depletion carryforward

$

181,000  

 

181,000  

 Net operating loss carryforward

 

418,000  

 

395,000  

 Accrued shareholder salary

 

246,000  

 

228,000  

 Deletion and amortization

 

2,000  

 

2,000  

Total Net Deferred Tax Assets

 

847,000  

 

806,000  

 Less valuation allowance

 

(847,000) 

 

(806,000) 

Net Deferred Tax Asset

$

 

 

 

 

 

A valuation allowance has been provided because of the uncertainty of future realization. Income tax expense is different from amounts computed by applying the statutory Federal income tax rate for the following reasons:

 

 

2025

2024

Tax expense (benefit) at 21% of net earnings (loss)

$

(40,000)

92,000 

Change in valuation allowance for net deferred tax assets

 

40,000 

(92,000)

Income tax expense

$

 

As of September 30, 2025, the Company has no unrecognized tax benefit as a result of uncertain tax positions. As of September 30, 2025, the Company’s tax years that remain subject to examination are 2022 - 2025 (Federal jurisdiction) and 2021 - 2025 (state jurisdictions).